The Vanguard Group 13D and 13G filings for Abbott Laboratories:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:55 pm Purchase | 2023-12-29 | 13G | Abbott Laboratories ABT | The Vanguard Group | 156,444,700 9.010% | 963,906 (+0.62%) | Filing |
| 2023-02-09 10:54 am Purchase | 2022-12-30 | 13G | Abbott Laboratories ABT | The Vanguard Group | 155,480,794 8.920% | 6,328,530 (+4.24%) | Filing |
| 2022-02-09 3:15 pm Purchase | 2021-12-31 | 13G | Abbott Laboratories ABT | The Vanguard Group | 149,152,264 8.430% | 1,879,344 (+1.28%) | Filing |
| 2021-02-10 10:30 am Sale | 2020-12-31 | 13G | Abbott Laboratories ABT | The Vanguard Group | 147,272,920 8.310% | -4,510,516 (-2.97%) | Filing |
| 2020-02-12 09:16 am Purchase | 2019-12-31 | 13G | Abbott Laboratories ABT | The Vanguard Group | 151,783,436 8.580% | 7,519,763 (+5.21%) | Filing |